Menu
Back to Archived Journals » Core Evidence » Volume 3 » Issue 1
Core Evidence ceased publishing in January 2023. All articles that have been published in Core Evidence will continue to be available on the Dove Press site, and will be securely archived with CLOCKSS.
Core Evidence
ISSN: 1555-175X
- View all (143)
- Volume 15, 2020 (4)
- Volume 14, 2019 (6)
- Volume 13, 2018 (3)
- Volume 12, 2017 (2)
- Volume 11, 2016 (5)
- Volume 10, 2015 (9)
- Volume 9, 2014 (13)
- Volume 8, 2013 (7)
- Volume 7, 2012 (12)
- Volume 6, 2011 (7)
- Volume 5, 2010 (9)
- Volume 4, 2009 (20)
- Volume 3, 2008 (5)
- Volume 2, 2007 (22)
- Volume 1-Issues 3 & 4, 2006 (8)
- Volume 1-Issues 1 & 2, 2005 (11)
Archive: Volume 3, 2008
Review
Ivabradine: the evidence of its therapeutic impact in angina
Guillaume Marquis-Gravel, Jean-Claude Tardif
Core Evidence 2008, 3:0-0
Published Date: 31 December 2008
Review
Omalizumab: the evidence for its place in the treatment of allergic asthma
Diarmuid M. McNicholl, Liam G. Heaney
Core Evidence 2008, 3:0-0
Published Date: 31 December 2008
Review
Prucalopride: the evidence for its use in the treatment of chronic constipation
Georges Coremans
Core Evidence 2008, 3:0-0
Published Date: 31 December 2008
Review
Tolvaptan: the evidence for its therapeutic value in acute heart failure syndrome
Arash Aghel, W. H. Wilson Tang
Core Evidence 2008, 3:0-0
Published Date: 31 December 2008
Review
Vildagliptin: the evidence for its place in the treatment of type 2 diabetes mellitus
Louise Profit, Paul Chrisp, Carole Nadin
Core Evidence 2008, 3:0-0
Published Date: 31 December 2008